Overview
The School of Pharmacy (SoP) focuses its research activities on key areas of the pharmaceutical sciences, clinical and primary care aspects of pharmacy. Our research spans a wide range of scientific and professional disciplines. Multidisciplinary sits at the core of many of our internationally-connected research programmes, ultimately delivering impactful research designed to benefit patients.
The School of Pharmacy is committed to research excellence. This is achieved through ambitious target setting, a key feature of our School Strategy, feeding into the broader University Strategy 2030. We will continually strive for research excellence, strategic recruitment and encourage/enable impactful internal and external collaborations. The SoP has as a broad portfolio of high quality research income and staff within the School publish widely in leading journals and present their work at national and international conferences.
Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice. Research programmes are grouped into five key themes, which are mainly funded by UK/European Government sources, leading medical charities and importantly the pharmaceutical industry.
1. NANOMEDICINE AND BIOTHERAPEUTICS
This area focus on the development of novel technologies and targeted therapies for advanced healthcare solutions including anticancer therapeutics, nanoparticles and nano-delivery of macromolecules; proteases in disease and natural peptides.
http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/NanomedicineandBi
2. PHARMACEUTICAL MATERIALS SCIENCE AND FORMULATION
This activity centres on the design, development and industrial translation of novel systems for patient-focused administration of difficult-to-deliver drugs including; HIV prevention and multipurpose prevention technologies; solid dosage forms and microneedles.
http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/PharmaceuticalMate
3. DRUG DELIVERY AND BIOMATERIALS
The area investigates the development of materials which interface with the body, providing enhanced functionality. Applications include improved drug delivery, infection resistance or monitoring of levels of drug or host markers. The three main areas are: photoactive biomaterials, polymeric medical devices and sensor development.
http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/DrugDeliveryandBio
4. INFECTION AND ANTIMICROBIAL RESISTANCE
This research theme consists of both basic and clinical research to improve the prevention, detection and treatment of infection, in particular for respiratory infectious diseases, antimicrobial stewardship and novel antimicrobials and anti-infective biomaterials
http://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/InfectionandAntimicr
5. HEALTHCARE DELIVERY AND MEDICINES OPTIMISATION
Reaearch within heath care delivery and medicines optimisation encompasses the development and implementation of interventions that improve the health outcomes for patients in primary and secondary care. This includes systems of healthcare delivery; quality of care in vulnerable populations and clinical paediatrics
https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/ResearchThemes/HealthcareDeliveryandMedicinesOptimisation/
Subject Summary
Research within the School of Pharmacy covers a broad range of disciplines, ranging from material science, to drug discovery and clinical pharmacy. As such prospective students will have the benefit of working within a multi-disciplinary environment, with access to world class facilities and global leaders in their respective research areas.
Pharmacy Highlights
World Class Facilities
- The Graduate School is a dedicated, University wide facility designed to connect postgraduate students from across all disciplines. It is located on the main site, within the recently renovated Lynn Library. The Graduate School provides an array of valuable training opportunities, tailor built to meet the needs of our postgraduate community. Importantly, courses are designed to provide support for core generic skills and for subject specific topics. Additionally, areas with the Graduate School can be reserved by postgraduate providing an idyllic retreat for those times which require intense focus.
More information about the Graduate School, can be found below:
https://www.qub.ac.uk/graduate-school/
Internationally Renowned Experts
- These unique research programmes are delivered by numerous leading international academic experts in specialist fields including drug delivery, medical devices and nanotechnology. Details of specific staff, with links to their areas of research expertise can be located below:
https://www.qub.ac.uk/schools/SchoolofPharmacy/Research/
Student Experience
- 89% of current PhD students with the School of Pharmacy agree that the supervisory support and feedback equips them with the knowledge and experience to complete their research degree (PRES 2021).
Key Facts
Course content
Research Information
Associated Research
School of Pharmacy works closely with both local and global pharmaceutical companies. This ensures a successful pipeline for the development of novel emerging healthcare technologies, designed specifically to deliver patient benefit.
Research Themes
NANOMEDICINE AND BIOTHERAPEUTICS
Research in this theme is focused on the development of novel technologies and targeted therapies for advanced healthcare solutions. Activities are concentrated on the development of unique genetic therapies and delivery systems that can be applied for the detection and treatment of various disease condition, design and commercial translation of novel nanomedicines with a focus on cancer treatment, the detection, characterisation and inhibition of proteases implicated in chronic diseases, the isolation and characterisation of bioactive peptides for potential therapeutic use and computational biology for drug design and molecular modelling.
Research Themes
PHARMACEUTICAL MATERIALS SCIENCE AND FORMULATION
Research in this theme is focused on the design, development and industrial translation of novel systems for patient-focused administration of difficult-to-deliver drugs. Activities are concentrated on the development of formulations to address major global issues around sexual and reproductive health, use of hot melt granulation and polymer extrusion/injection moulding technologies to produce solid dosage forms, multi-layered and targeted drug delivery systems, the use microneedles for transdermal drug delivery, patient monitoring and vaccine delivery, implantable delivery systems and ocular therapeutics.
Research Themes
DRUG DELIVERY AND BIOMATERIALS
Research in this theme is focused on the development of materials which interface with the body and provide enhanced functionality, such as drug delivery, infection resistance or monitoring of levels of drug or host markers. Activities are concentrated on the development of new methods for fabricating materials for medical device manufacture including biomaterials with enhanced anti-infective and biocompatibility properties. Sensor research focuses on sensors immobilised in biocompatible scaffolds, blood-free diagnosis/patient monitoring using microneedles and developing point-of-care tests for microbial infection.
Research Themes
INFECTION AND ANTIMICROBIAL RESISTANCE
Research in this theme is focused on improved prevention, detection and treatment of infection. Activities are concentrated on preventing the development of antimicrobial resistance through improved antimicrobial stewardship, improved detection of infection using molecular and sensor based technology, prevention of infection using novel anti-infective biomaterials and enhanced infection prevention and control strategies and improved treatment of infection through discovery of novel antibiotics and antibiotic adjuvants and markers for better evidence-based decisions on antibiotic selection.
Research Themes
HEALTHCARE DELIVERY AND MEDICINES OPTIMISATION
Research in this theme is focused on the development and implementation of interventions that improve the health outcomes of patients in primary and secondary care. Activities are concentrated on improving systems of patient care in all health care sectors with a focus on the appropriateness of prescribing in chronic disease and in care home residents with dementia, and medication adherence in children.
Research Themes
The School of Pharmacy at Queen’s is widely acknowledged as a leading centre for Pharmacy teaching and research in the UK. We are currently ranked 2nd School of Pharmacy in the UK for Pharmacy and Pharmacology Research
(The Complete University Guide 2022)
PhD opportunities are available in:
•Nanomedicine and biotherapeutics
•Pharmaceutical materials science and formulation
•Drug delivery and biomaterials
•Infection and antimicrobial resistance
•Healthcare delivery and medicines optimisation
Research Themes
Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice. REF 2021 showed that 97% of the School’s submitted research fell within the highest quality 4* and 3* categories, with 43% classed as world- leading 4* research.
The School of Pharmacy has a long-standing track record in undertaking research which has had impact on healthcare and wellbeing for the population. Our work has led to the development of a local anaesthetic cream formulation, the creation of several spin-out companies (e.g. ProAxsis, pHion Therapeutics, Re-Vana Therapeutics), devices to help prevent the spread of HIV and a new type of pharmacy-led service which improves the prescribing of medication for older people. We constantly strive to do research which will positively impact society and improve the delivery of health care. One example of our high impact research includes the BREATH project led by Professor Lorraine Martin (https://www.breath-copd.org).
Research Projects
Materials & Advanced Technologies for Healthcare (MATCH) is an interdisciplinary research initiative comprising leading researchers from the Schools of Pharmacy, Chemistry & Chemical Engineering, Mechanical and Aerospace Engineering, Biological Sciences, Medicine, Dentistry & Biomedical Sciences and Nursing & Midwifery.
Our research is based on one key question: “How can we use advanced technologies to significantly improve healthcare outcomes?” We connect researchers along the development pathway and follow a unique “Molecule to Patient” approach. Currently, single-stranded strategies are applied to development and use of new healthcare products. Without a holistic approach, medicines are wasted, patients suffer avoidable adverse effects, or go untreated. Greater interaction between those involved in identifying novel therapeutic targets, drug discovery, materials science, pharmaceutical formulation, manufacture, diagnosis, prescribing and medicines utilisation is a significant unmet need. If addressed, this stands to have major impact in the care of all patients, but especially the very young and old, representing the populations in which medicines may present the greatest risk, but have maximum benefit. We take an innovative dual approach, firstly by developing the underpinning technologies, secondly by exploiting the possibilities that these technologies present to maximum clinical and commercial advantage by selecting the best target areas and understanding patient factors.
Research Success
The research profile produced by the 2021 UK Research Excellence Framework (REF) showed that 97% of the research outputs with our combined Allied Health Professions, Dentistry, Nursing and Pharmacy submission fell within the highest quality 4* and 3* categories, with 51% classed as world-leading 4* research, confirming our reputation as an internationally-leading research centre. Excellence across the School of Pharmacy is evidenced by our consistent ranking as one of the top pharmacy schools within the UK. We are very proud that in 2022 our School was ranked by the QS World Rankings in the top 15% (55th) globally for Pharmacy and Pharmacology.
Career Prospects
Introduction
Many of our PhD graduates have moved into academic and research roles in Higher Education while others go on to play leading roles within the pharmaceutical industry. Queen's postgraduates reap exceptional benefits from facilities within the School, but also from wider University initiatives, such as Degree Plus and Researcher Plus, both of which bolster candidate employability.
Employment after the Course
Queen’s University offer extensive career development opportunities to PhD students. Further details can be accessed via the link below.
https://www.qub.ac.uk/directorates/sgc/careers/
People teaching you
Professor Brendan Gilmore
PGR Director
Pharmacy
Applications considered throughout the year from applicants who have secured external funding or are willing to self-fund the project.
Learning Outcomes
A research degree offers students an opportunity to develop their capacity for independent research and critical thought. A PhD allows students to explore in-depth an area of interest, developing skills to solve theoretical and practical problems within the field. Undertaking a research degree will enhance a student’s written and oral communication skills, providing the essential skills required for academic and industry leadership positions.
Course structure
There is no specific course content as such. You are expected to undertake 30 days of formal training which includes demonstrator training, laboratory techniques, annual progress review preparation etc. All students are closely supported by the School and supervisors to obtain quantitative and qualitative data using a range of research methods. You will be expected to carry out your own research under the guidance of your supervisor and postdoctoral team.
Over the course of study you can attend postgraduate skills training organised by the Graduate School.
You will normally register, in the first instance, as an ‘undifferentiated PhD student’ which means that you have satisfied staff that you are capable of undertaking a research degree. The decision as to whether you should undertake an MPhil or a PhD is delayed until you have completed ‘differentiation’.
Differentiation takes place about 9-12 months after registration for full time students and about 18-30 months for part time students: You are normally asked to submit work to a panel of up two academics and this is followed up with a formal meeting with the ‘Differentiation Panel’. The Panel then make a decision regarding your progress and the viability of your research project. Annual progress reviews, with the same panel will occur both during 2nd and 3rd year.
To complete a doctoral qualification you will be required to submit a thesis and to attend a viva voce [oral examination] with an external and internal examiner to defend your research.
A PhD programme runs for 3 years full-time or 6 years part-time. Students can apply for a writing up year should it be required.
The PhD is open to both full and part time candidates and is often a useful preparation for a career within academia or industry.
Full time students are often attracted to research degree programmes because they offer an opportunity to pursue in some depth an area of academic interest.
If you meet the Entry Requirements, the next step is to check whether we can supervise research in your chosen area. We only take students to whom we can offer expert research supervision from one of our academic staff. Therefore, your research interests should align with those of our academic staff. Full details can be found via the website.
https://www.qub.ac.uk/courses/postgraduate-research/find-a-phd-supervisor/
Application Process
If you identify a potential PhD supervisor, select the “Make a PhD enquiry” tab, and complete the required fields. Your potential supervisor or the admissions team will aim to respond within a working week.
Following initial discussions, and assuming you meet the eligibility criteria, potential students will need to make a formal application for PhD study via the link below. This application will require a brief outline of the proposed research project. This can be agreed with your potential supervisor during initial discussions.
https://dap.qub.ac.uk/portal/user/u_login.php
If you have difficulty identifying or contacting an appropriate supervisor, please contact Dr Heather Barry (h.barry@qub.ac.uk) or Adam Ringland (a.ringland@qub.ac.uk) who will be happy to help.
Application from full-time self-funding students will be accepted at any point throughout the academic year.
Assessment
Students will be expected to present drafts of their work at regular intervals to their supervisor who will provide written and oral feedback; a formal assessment process takes place annually, termed the Annual Progress Review (APR).
APR requires students to present their work in both the written and oral format to a panel of academics from within the School. Successful completion of this process will allow students to register for the next academic year.
Students will be expected to present drafts of their work at regular intervals to their supervisor who will provide written and oral feedback; a formal assessment process takes place annually, termed the Annual Progress Review (APR).
APR requires students to present their work in both the written and oral format to a panel of academics from within the School. Successful completion of this process will allow students to register for the next academic year.
The final assessment of the doctoral degree is both written and oral. Students will submit their thesis to an internal and external examining team who will review the written thesis before inviting the student to orally defend their work at a Viva Voce.
Feedback
Supervisors will offer feedback on draft work at regular intervals throughout the period of registration on the degree.
Facilities
Full time PhD students will have access to a shared office space and access to a desk with personal computer and internet access.
Learning and Teaching
This is a research degree
-
-
Project name | School | Funding | Subject | Status | Sort | Timestamp |
---|---|---|---|---|---|---|
Nanocrystals-in-nanofibres as a promising strategy for the delivery of poorly soluble activesSchool of Pharmacy | PHD Nanocrystals, nanotechnology, drug delivery, pharmaceutics Dr Alejandro J. Paredes (CAST)
Supervisor
Dr Alejandro J. Paredes (CAST)
Funding
Funded
Department of the Economy (DfE) CAST award
Application deadline
22 November 2024
|
School of Pharmacy | Funded | Pharmacy | Closed | 2 | 1732233600 |
Microneedle delivery of non-ribosomal antimicrobial peptides to treat multidrug-resistant Gram-negative infectionsSchool of Pharmacy | PHD Antibiotics; peptide synthesis; antimicrobial peptides; microneedles; organic synthesis Professor Ryan Donnelly.
Supervisor
Professor Ryan Donnelly.
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Chemical Tools to Tackle Antimicrobial ResistanceSchool of Pharmacy | PHD Antibiotics; peptide synthesis; chemical probes; organic synthesis; chemical biology Professor Gerd Wagner.
Supervisor
Professor Gerd Wagner.
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
ENERGY - Enhanced Nanoparticles Engineered fRom Gold for multi-modal therapYSchool of Pharmacy | PHD Nanomedicine, Cancer, SERS, radiotherapy, photothermal therapy Professor Jonathan Coulter.
Supervisor
Professor Jonathan Coulter.
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
High resolution solid state NMR as a tool for analysis of polymeric controlled release drug delivery systemsSchool of Pharmacy | PHD Drug delivery, materials science, analytical chemistry, polymers, solid state NMR Professor Karl Malcolm.
Supervisor
Professor Karl Malcolm.
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Investigating the impact of electronic cigarette vapour on respiratory microbiota and inflammation.School of Pharmacy | PHD Electronic cigarettes, smoking, vaping, microbiology, respiratory, infection Dr Deirdre Gilpin
Supervisor
Dr Deirdre Gilpin
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Monitoring antimicrobial resistance in wastewater in Northern Ireland.School of Pharmacy | PHD Microbiology, infection, antimicrobial resistance Dr Deirdre Gilpin
Supervisor
Dr Deirdre Gilpin
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
To investigate novel interacting drug combinations in the treatment of Ovarian CancerSchool of Pharmacy | PHD Ovarian Cancer, cell biology, cell signalling, pharmacology, drug action Dr Fiona Furlong
Supervisor
Dr Fiona Furlong
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Closed | 2 | |
Utilising data linkage to estimate antimicrobial resistance burden in paediatric populationsSchool of Pharmacy | PHD Pharmacoepidemiology, data linkage, antimicrobial resistance, children Dr Yingfen Hsia
Supervisor
Dr Yingfen Hsia
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Treatment of infections caused by multidrug-resistant Gram-negative infections through microneedle delivery of antimicrobial peptidesSchool of Pharmacy | PHD Antibiotics, peptide synthesis, antimicrobial peptides, microneedles, organic synthesis Prof Ryan Donnelly
Supervisor
Prof Ryan Donnelly
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Production of super small nanocrystals for drug delivery to target tissuesSchool of Pharmacy | PHD Drug nanocrystals, media milling, infectious diseases, nanoparticle, targeting Dr Alejandro J. Paredes
Supervisor
Dr Alejandro J. Paredes
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Antibiotic Resistance and Biofilm Formation in Clinical Isolates of Enterococcus faecium – a WHO High Priority PathogenSchool of Pharmacy | PHD Microbiome, extremophile, enzymes, biocatalysis, biotechnology Professor Brendan Gilmore
Supervisor
Professor Brendan Gilmore
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Cold Plasmas for Enhancement of Intracellular Delivery of MacromoleculesSchool of Pharmacy | PHD Microbiome, extremophile, enzymes, biocatalysis, biotechnology Professor Brendan Gilmore
Supervisor
Professor Brendan Gilmore
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Measurement of outcomes for medicines management interventions for people living with dementia in primary careSchool of Pharmacy | PHD Dementia, core outcome set, interventions, outcome measurement instruments, systematic review Professor Carmel Hughes
Supervisor
Professor Carmel Hughes
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Access to medicines by older people in low and middle-income countries: a mixed methods studySchool of Pharmacy | PHD Pharmaceutical policy, access to medicines, older people, low and middle income countries Professor Carmel Hughes.
Supervisor
Professor Carmel Hughes.
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Self-regulating, self-cleaning biomaterialsSchool of Pharmacy | PHD Drug delivery, antimicrobial, AMR, polymer, materials science, surface modification, surface chemist Professor Colin McCoy
Supervisor
Professor Colin McCoy
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Smart, responsive biomaterials for infection-resistant medical devicesSchool of Pharmacy | PHD Drug delivery, antimicrobial, AMR, polymer, materials science, surface modification, surface chemist Professor Colin McCoy
Supervisor
Professor Colin McCoy
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Pharmacist-led medicines optimisation case management services: evaluation and development of the Medicines Optimisation in Older People (MOOP) modelSchool of Pharmacy | PHD Dementia, pain, long-term care, nursing homes Dr Carole Parsons
Supervisor
Dr Carole Parsons
Funding
Unfunded
Application deadline
31 January 2025
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | 1738281600 |
Microfluidic technologies for the production of NanomedicinesSchool of Pharmacy | PHD Drug Delivery, Microfluidics, Nanomedicine, Biopharmaceutics Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Microfluidic Encapsulation of biologics into NanomedicinesSchool of Pharmacy | PHD Microfluidics, Biopharmaceutics, Nanomedicine, Drug Delivery, Additive Manufacturing Professor Dimitrios Lamprou.
Supervisor
Professor Dimitrios Lamprou.
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
3D & 4D printing in cancer managementSchool of Pharmacy | PHD 3D Printing, 4D printing, Bioprinting, Drug Delivery, Cancer treatment, Implants Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Microfluidic technologies applied to respiratory diseasesSchool of Pharmacy | PHD 3D Printing, lab-on-a-chip, Drug Delivery, Pharmaceutical Technology Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Funded
Chiesi Farmaceutici Ph.D. Studentship
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Closed | 2 | |
Novel strategies and innovative technologies to produce amorphous solid dispersionSchool of Pharmacy | PHD Bioengineering, Biomechanics, Biomedical Engineering, Chemical Engineering, Pharmaceutical Chemistry Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Closed | 2 | |
Design and Evaluation of an eye-on-a-chip Microfluidic DeviceSchool of Pharmacy | PHD Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
4D printed Biomaterials in cancer therapeuticsSchool of Pharmacy | PHD 3D Printing, 4D printing, Bioprinting, Drug Delivery, Cancer treatment, Implants Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Microfluidic Encapsulation of biologics into NanomedicinesSchool of Pharmacy | PHD pharmaceutics, microfluidics, nanomedicines, drug delivery, biologics Professor Dimitrios Lamprou
Supervisor
Professor Dimitrios Lamprou
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Bioactive, biodegradable coatings for urinary medical devicesSchool of Pharmacy | PHD Infection, medical device, biodegradable polymers, degradation Professor David Jones
Supervisor
Professor David Jones
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Sustained Release of Eutectic systems composed of Local Anaesthetics and non-steroidal anti-inflammatory agents from biodegradable electrospun mats to Enhance Post-Surgical RecoverySchool of Pharmacy | PHD Infection, medical device, biodegradable polymers, degradation Professor David Jones
Supervisor
Professor David Jones
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Developing biodegradable long acting drug delivery systems for the treatment of chronic conditionsSchool of Pharmacy | PHD drug delivery / long-acting drug delivery / medical devices / 3D printing / implantable drug deliver Professor Eneko Larrañeta
Supervisor
Professor Eneko Larrañeta
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
3D-printing of implantable devices for sustained drug deliverySchool of Pharmacy | PHD Pharmaceutics, Bioengineering, Formulation Sciences Professor Eneko Larrañeta.
Supervisor
Professor Eneko Larrañeta.
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Peptide-based nanoparticles for brain targeted gene delivery to treat neurodegenerative diseases.School of Pharmacy | PHD Cell Penetrating Peptides, Gene Delivery, Gene Therapy, Nanomedicine, Targeted Treatments Dr Emma McErlean.
Supervisor
Dr Emma McErlean.
Funding
Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Genetic Engineering of Immune Effector Cells for CAR therapies using a Peptide TechnologySchool of Pharmacy | PHD Cell Penetrating Peptides, Gene Delivery, Gene Therapy, Nanomedicine, Targeted Treatments, Ex vivo A Dr Emma McErlean.
Supervisor
Dr Emma McErlean.
Funding
Funded
Department for the Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Dissecting mechanism of drug responses to novel anti-cancer therapiesSchool of Pharmacy | PHD Dr Fiona Furlong
Supervisor
Dr Fiona Furlong
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Elucidating novel anti-cancer drug responses in advanced ovarian cancerSchool of Pharmacy | PHD Keywords for search filters Ovarian Cancer; cell biology; cell signalling; pharmacology; drug act Dr Fiona Furlong
Supervisor
Dr Fiona Furlong
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of antifungal nanotherapeutics containing AmB+ drug combinations using an advanced continuous manufacturing technologySchool of Pharmacy | PHD Antifungal, Pharmaceutical Technology, nanomedicine, liposomes, polymeric nanoparticles Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of paediatric-centred anti-malaria nanotherapeutic formulations using an advanced continuous manufacturing technologySchool of Pharmacy | PHD ACT, Malaria, Pharmaceutical Technology, nanomedicine, nanoparticles, continuous manufacturing Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of Innovative Diabetic Foot Ulcer Treatment Strategies using Photodynamic Therapy + Combination Delivery SystemsSchool of Pharmacy | PHD Diabetes, Diabetic Foot ulcer, Pharmaceutical Technology, Photodynamic therapy Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Developing magneto-electric nanoparticles for advanced drug delivery of therapeutic agents for the treatment of neurological tuberculosis and HIVSchool of Pharmacy | PHD Nanomedicine, Nanotechnology, Nanomaterials, Nanoparticles, Central nervous system, Drug delivery Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of Solid-state Therapeutic Protein Formulations for Oral Delivery via Advanced and Continuous Manufacturing TechnologiesSchool of Pharmacy | PHD Therapeutic proteins, solid-state protein formulations, oral protein delivery, hot melt extrusion Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of Variable Dose Combination Products Using FDM 3D PrintingSchool of Pharmacy | PHD Personalised medicine, precision medicine, stratified therapy, fixed dose combination Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
The Development of Innovative Indwelling Medical Devices containing Biosensor TechnologySchool of Pharmacy | PHD Professor Gavin Andrews
Supervisor
Professor Gavin Andrews
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
The Development of a Robust Risk-Based Approach to the use of Hot Melt Extrusion for the Manufacture of Amorphous Solid DispersionsSchool of Pharmacy | PHD Hot-Melt Extrusion (HME), Amorphous Solid Dispersions (ASDs), API–Polymer Phase Diagrams, Professor Gavin Andrews.
Supervisor
Professor Gavin Andrews.
Funding
Funded
DfE Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
The Development of Implantable Anti-tumour Devices for Enhanced Efficacy of Repurposed Drugs Using Advanced ManufacturingSchool of Pharmacy | PHD Pharmaceutics Pharmaceutical Engineering Pharmaceutical Science Professor Gavin Andrews..
Supervisor
Professor Gavin Andrews..
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Enzyme-responsive peptide hydrogel as in situ forming long-acting drug delivery implantsSchool of Pharmacy | PHD Drug Delivery, Peptides; Hydrogels; Controlled Release Dr Garry Laverty
Supervisor
Dr Garry Laverty
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Peptide-like hydrogels: A post-surgical sustained release drug delivery implant for the treatment of glioblastoma brain tumoursSchool of Pharmacy | PHD Hydrogel; drug delivery; formulation; long-acting implant; biomaterials; peptides; brain tumours, ca Dr Garry Laverty
Supervisor
Dr Garry Laverty
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Peptide-like hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV preventionSchool of Pharmacy | PHD Hydrogel; drug delivery; formulation; long-acting injectable; peptides; HIV Dr Garry Laverty
Supervisor
Dr Garry Laverty
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Peptide-like hydrogels as long-acting injectable drug delivery platforms for the prevention of malariaSchool of Pharmacy | PHD Hydrogel; drug delivery; formulation; long-acting injectable; peptides; malaria Dr Garry Laverty
Supervisor
Dr Garry Laverty
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Peptide-like hydrogels as long-acting injectable drug delivery platforms for the prevention of tuberculosisSchool of Pharmacy | PHD Hydrogel; drug delivery; formulation; long-acting injectable; peptides; tuberculosis Dr Garry Laverty
Supervisor
Dr Garry Laverty
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Chemical glycoengineering of therapeutic antibodiesSchool of Pharmacy | PHD drug design, chemical biology, medicinal chemistry, organic synthesis, antibodies Professor Gerd Wagner
Supervisor
Professor Gerd Wagner
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Novel P2Y receptor ligands for drug discoverySchool of Pharmacy | PHD drug design, chemical biology, medicinal chemistry, organic synthesis, nucleoside, nucleotide, GPCR Professor Gerd Wagner
Supervisor
Professor Gerd Wagner
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Covalent inhibitors of a bacterial enzyme as novel antimicrobial resistance breakersSchool of Pharmacy | PHD Professor Gerd Wagner
Supervisor
Professor Gerd Wagner
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Breaking the resistance: alternative approaches to antibiotics discoverySchool of Pharmacy | PHD antimicrobial resistance, chemical biology, medicinal chemistry, biochemistry, organic synthesis, dr Professor Gerd Wagner
Supervisor
Professor Gerd Wagner
Funding
Unfunded
DfE Funded - Deadline 31st Jan 2024
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
The role of carers in medicines management for people living with dementiaSchool of Pharmacy | PHD Older people, dementia, carers, primary care, healthcare professionals, medicines management Dr Heather Barry
Supervisor
Dr Heather Barry
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
An exploration of non-prescription medication use amongst older adultsSchool of Pharmacy | PHD Older people, non-prescription medication use, prescribing, primary care, healthcare professionals, Dr Heather Barry
Supervisor
Dr Heather Barry
Funding
Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of a Dual Nanogel for Junctional Epidermolysis BullosaSchool of Pharmacy | PHD Nanoparticles, Hydrogel, Junctional Epidermolysis Bullosa, mRNA Therapeutics, Nanomedicine Professor Helen McCarthy
Supervisor
Professor Helen McCarthy
Funding
Funded
DEBRA UK
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Structure-based design of allosteric modulators for G protein-coupled receptors using molecular modelling and pharmacology experimentsSchool of Pharmacy | PHD computational biology, protein-coupled receptors, molecular modelling Dr Irina Tikhonova
Supervisor
Dr Irina Tikhonova
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Computational and Functional Comprehensive Analysis of Natural Variants of GPCRs towards a personalized medicine approachSchool of Pharmacy | PHD Molecular modelling, pharmacology, drug design, functional assays Dr Irina Tikhonova
Supervisor
Dr Irina Tikhonova
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Regulation of CaaX protein processingSchool of Pharmacy | PHD Protease, ubiquitin, deubiquitinase, USP17 Dr James Burrows
Supervisor
Dr James Burrows
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Does one size fit all for antimicrobial delivery via nanoparticlesSchool of Pharmacy | PHD Antimicrobial, nanoparticles, bacteria, intracellular Dr James Burrows
Supervisor
Dr James Burrows
Funding
Unfunded
DfE Funding
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Improving antimicrobial delivery via nanoparticlesSchool of Pharmacy | PHD Antimicrobial, nanoparticles, bacteria, intracellular Dr James Burrows & Professor Brendan Gilmore
Supervisor
Dr James Burrows & Professor Brendan Gilmore
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Exploring the regulation of cancer cell movement by USP17School of Pharmacy | PHD USP17, cancer, ubiquitin, protease, migration, metastases Dr James Burrows
Supervisor
Dr James Burrows
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Countering the proteinase-activated receptor 1 (PAR-1) pro-tumour phenotype using a novel nanotherapeutic approachSchool of Pharmacy | PHD Cancer biology, Nanomedicine, Drug Delivery, metastasis Professor Jonathan Coulter
Supervisor
Professor Jonathan Coulter
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Developing and characterising novel targeted nanocomposites serving as adjuvants to existing standard-of-care cancer treatmentsSchool of Pharmacy | PHD Cancer biology, Nanomedicine, Drug Delivery, metastasis Professor Jonathan Coulter
Supervisor
Professor Jonathan Coulter
Funding
Funded
DfE Funding, International scholarship support / S
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Digital design and advanced processing technologies for antimicrobial nanotherapeuticsSchool of Pharmacy | PHD Antifungal, antibacterial, nanomedicine, liposomes, Dr Justin Tian
Supervisor
Dr Justin Tian
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
High throughput exploration of the design space for antifungal nanocarrier developmentSchool of Pharmacy | PHD Antifungal, antibacterial, liposomes, polymeric nanoparticles, rational design, Dr Justin Tian
Supervisor
Dr Justin Tian
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
A systematic screening tool for nanocarrier design and efficient drug delivery against biological barriers.School of Pharmacy | PHD Micro/nanofibration, soft lithography, microrheology, microfluidics, systematic approach; molecular Dr Justin Tian
Supervisor
Dr Justin Tian
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Structural Exploration for Antifungal Nanocarriers DevelopmentSchool of Pharmacy | PHD Antifungal, nanomedicine, fungal biofilm, advanced imaging techniques, high throughput screening Dr Justin Tian
Supervisor
Dr Justin Tian
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Dexamethasone-releasing cochlear implants for fibroblast growth inhibitionSchool of Pharmacy | PHD Drug delivery; pharmaceutics; medical devices Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Funded
Application deadline
15 November 2024
|
School of Pharmacy | Funded | Pharmacy | Closed | 2 | 1731628800 |
Development of a silicone elastomer vaginal ring for controlled release estrogen replacement therapySchool of Pharmacy | PHD silicone elastomer; reservoir-type vaginal ring; controlled release drug delivery; estrogen replacem Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Funded
Millicent Pharma
Application deadline
8 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1736294400 |
Novel poly(acrylic acid) complexes for enantioselective drug delivery and chiral separationSchool of Pharmacy | PHD Drug delivery, materials science, analytical chemistry, polymers, solid state NMR Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
3D-printed drug-eluting auxetic meshes for preventing biofilm formation and capsular contracture associated with breast implantsSchool of Pharmacy | PHD Surgical meshes, capsular contracture, drug delivery, breast implants, 3D printing, auxetic material Professor Karl Malcolm..
Supervisor
Professor Karl Malcolm..
Funding
Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Multipurpose gel formulations containing antiretroviral-loaded lactoferrin nanoparticles and antibiotics for combination HIV prevention and treatment of bacterial vaginosisSchool of Pharmacy | PHD Lactoferrin; antiretroviral; HIV prevention; vaginal gel; multipurpose prevention technology (MPT); Professor Karl Malcolm...
Supervisor
Professor Karl Malcolm...
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Dip-coating as a strategy to modify drug release from silicone elastomer drug delivery devicesSchool of Pharmacy | PHD Drug delivery, materials science, analytical chemistry, polymers, drug release kinetics Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
A new combination drug delivery product for improved treatment of bacterial vaginosisSchool of Pharmacy | PHD pharmaceutics; drug delivery; drug formulation; microbiology Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Combination drug strategies for treatment of aerobic vaginitisSchool of Pharmacy | PHD women’s sexual & reproductive health; bacterial assays; drug delivery; drug formulation, gels ,rings Professor Karl Malcolm
Supervisor
Professor Karl Malcolm
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of silicone-based personal lubricant products containing antiretroviral drugs for prevention of sexual acquisition of HIV infectionSchool of Pharmacy | PHD HIV/AIDS; sexual and reproductive health; personal lubricants; silicone Prof Karl Malcolm
Supervisor
Prof Karl Malcolm
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
A proliposomal strategy for enhancing solubility and absorption of drugs delivered from controlled release vaginal ring devices School of Pharmacy | PHD Prof Karl Malcolm.
Supervisor
Prof Karl Malcolm.
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Multifunctional Biomaterials to Combat Infection and Modulate InflammationSchool of Pharmacy | PHD Biomaterials, Medical Device, Infection, Biofilm, Inflammation, Immunomodulatory, Implant, Regenerat Dr Louise Carson
Supervisor
Dr Louise Carson
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Selective targeting of proteases for the treatment of chronic airways disease.School of Pharmacy | PHD lung, respiratory, airways, COPD, proteases, cell biology, molecular biology, biochemistry, electrop Professor Lorraine Martin
Supervisor
Professor Lorraine Martin
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Molecular Silencing of Epithelial Sodium Channel (ENaC) using a Peptide Technology to Deliver Treatment for Cystic FibrosisSchool of Pharmacy | PHD Cystic Fibrosis, Gene Delivery, Gene Therapy, Cell Penetrating Peptides, Nanomedicine, Targeted Trea Professor Lorraine Martin.
Supervisor
Professor Lorraine Martin.
Funding
Funded
Department for the Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Investigation of novel protease-antiprotease imbalances associated with chronic airways disease.School of Pharmacy | PHD lung, respiratory, airways, COPD, proteases, cell biology, molecular biology, biochemistry, electrop Professor Lorraine Martin
Supervisor
Professor Lorraine Martin
Funding
Funded
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Selective targeting of furin for the treatment of fibrotic lung disease.School of Pharmacy | PHD lung, respiratory, airways, COPD, proteases, cell biology, molecular biology, biochemistry, electrop Professor Lorraine Martin
Supervisor
Professor Lorraine Martin
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Characterising biofilms in endotracheal tubes to direct a new strategy for preventing ventilator-associated pneumonia in critically ill adultsSchool of Pharmacy | PHD Dr Laura Sherrard
Supervisor
Dr Laura Sherrard
Funding
Unfunded
Microbiome, biofilm, infection, intensive care
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
PULSE-CF: Enhanced microbiological surveillance in people with Cystic Fibrosis (pwCF)School of Pharmacy | PHD Infection, molecular microbiology, microbiome, cystic fibrosis, bronchiectasis, respiratory medicine Professor Michael Tunney
Supervisor
Professor Michael Tunney
Funding
Funded
Cystic Fibrosis (CF) Trust and LifeArc
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Relationship between antibiotic therapy and development of antimicrobial resistance in patients with bronchiectasis and COPDSchool of Pharmacy | PHD Infection, antimicrobial resistance, PCR, next-generation sequencing, metagenomics Professor Michael Tunney
Supervisor
Professor Michael Tunney
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Surface enhanced Raman spectroscopy (SERS) for rapid antibiotic susceptibility testingSchool of Pharmacy | PHD Infection, antimicrobial resistance, antimicrobial susceptibility testing Raman spectroscopy Professor Michael Tunney
Supervisor
Professor Michael Tunney
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis AirwaysSchool of Pharmacy | PHD Infection, antimicrobial resistance, cystic fibrosis, mucin glycoproteins, liposome, micelle Professor Michael Tunney
Supervisor
Professor Michael Tunney
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development and evaluation of a lung-on-a chip device for screening novel antimicrobialsSchool of Pharmacy | PHD Infection, antimicrobial resistance, cystic fibrosis, microbiota, lab-on-a-chip, microfluidics Professor Michael Tunney
Supervisor
Professor Michael Tunney
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
PULSE-CF: Airway microbiome composition and pulmonary exacerbations in people with Cystic Fibrosis (pwCF)School of Pharmacy | PHD Infection, molecular microbiology, microbiome, cystic fibrosis, bronchiectasis, respiratory medicine Professor Michael Tunney.
Supervisor
Professor Michael Tunney.
Funding
Funded
Cystic Fibrosis (CF) Trust and LifeArc
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
PULSE-CF: Polymicrobial communities in the Cystic Fibrosis (CF) airways-role in infection and pulmonary exacerbations.School of Pharmacy | PHD Infection, molecular microbiology, microbiome, cystic fibrosis, bronchiectasis, respiratory medicine Professor Michael Tunney.
Supervisor
Professor Michael Tunney.
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Biomaterial coatings with lubricious, slippery coatings for improved urinary catheter performanceSchool of Pharmacy | PHD Biomaterials, urinary catheters, ionic liquids, infection, device coatings Dr Matthew Wylie
Supervisor
Dr Matthew Wylie
Funding
Funded
Department of Economy (DfE)
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Infection-responsive coatings for the prevention of catheter-associated urinary tract infectionsSchool of Pharmacy | PHD Biomaterials, urinary catheters, ionic liquids, infection, device coatings Dr Matthew Wylie
Supervisor
Dr Matthew Wylie
Funding
Funded
Department of Economy (DfE)
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Development of carbohydrate-functionalised materials for detection and prevention of medical device-associated infectionsSchool of Pharmacy | PHD Dr Matthew Wylie
Supervisor
Dr Matthew Wylie
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Designing next-generation urinary catheter materials for clean intermittent self-catheterisation through control of the urinary microbiomeSchool of Pharmacy | PHD Dr Matthew Wylie
Supervisor
Dr Matthew Wylie
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Advanced manufacturing of paediatric formulations with poorly water soluble drugsSchool of Pharmacy | PHD Advanced manufacturing; poorly water-soluble drugs; in situ amorphization; paediatric formulation Dr Min Zhao
Supervisor
Dr Min Zhao
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Microwave-induced in situ amorphization as a strategy for modulating drug release from silicone elastomer devices for controlled release drug deliverySchool of Pharmacy | PHD Poorly water-soluble drugs; Drug delivery, materials science, analytical chemistry, polymers Dr Min Zhao and Prof Karl Malcolm
Supervisor
Dr Min Zhao and Prof Karl Malcolm
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Developing novel therapeutic strategies to better treat Triple Negative Breast CancerSchool of Pharmacy | PHD Breast Cancer, biomarkers, personalised medicine Dr Niamh Buckley
Supervisor
Dr Niamh Buckley
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Investigating the clinical and molecular significance of the microbiome in breast cancerSchool of Pharmacy | PHD Breast cancer, personalised medicine, microbiome, biomarkers, novel therapies Dr Niamh Buckley
Supervisor
Dr Niamh Buckley
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
3D printing of drug delivery implantsSchool of Pharmacy | PHD Bone, biomaterials, hydroxyapatite, additive manufacturing, 3D printing Dr Peter Boyd
Supervisor
Dr Peter Boyd
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis.School of Pharmacy | PHD Cancer, Proteases, Cathepsins, Therapeutics, Personalised Medicine Dr Roberta Burden
Supervisor
Dr Roberta Burden
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Microneedle delivery systems for next-generation antibody therapeuticsSchool of Pharmacy | PHD Microneedles, antibodies, advanced therapeutics, drug delivery Professor Ryan Donnelly
Supervisor
Professor Ryan Donnelly
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Microneedle delivery systems for minimally-invasive patient diagnosis/monitoringSchool of Pharmacy | PHD Microneedles, antibodies, advanced therapeutics, drug delivery Professor Ryan Donnelly
Supervisor
Professor Ryan Donnelly
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
LONG-ACTING MICRONEEDLE DELIVERY SYSTEMSSchool of Pharmacy | PHD Microneedles, long-acting drug delivery Professor Ryan Donnelly
Supervisor
Professor Ryan Donnelly
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
MICRONEEDLE-MEDIATED CHEMICAL & ELECTROCHEMICAL RAPID INJECTION SYSTEMSSchool of Pharmacy | PHD Professor Ryan Donnelly
Supervisor
Professor Ryan Donnelly
Funding
Funded
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of long-acting injectable (LAI) drug delivery systems to treat ocular diseasesSchool of Pharmacy | PHD long-acting drug delivery, sustained release, polymer implants, glaucoma, ocular drug delivery Professor Raghu Raj Singh Thakur
Supervisor
Professor Raghu Raj Singh Thakur
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Innovative Drug Delivery Systems for Ocular Therapies: Micro- and Nano-Formulation ApproachesSchool of Pharmacy | PHD Drug delivery, Microparticles, Nanocarriers, Nanoparticles, sustained release, Ocular drug delivery Professor Raghu Raj Singh Thakur.
Supervisor
Professor Raghu Raj Singh Thakur.
Funding
Funded
Department of Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Design and Assessment of Innovative Long-Acting Drug Delivery SystemSchool of Pharmacy | PHD Drug delivery, sustained release, controlled release, long-acting, implants, biologics, protein deli Prof Raghu Raj Singh Thakur.
Supervisor
Prof Raghu Raj Singh Thakur.
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Self-Assembling Peptide Nanomaterials for Targeted Ocular Drug DeliverySchool of Pharmacy | PHD Drug delivery, sustained release, controlled release, peptide-based materials, hydrogels, ocular dru Prof Raghu Raj Singh Thakur
Supervisor
Prof Raghu Raj Singh Thakur
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development and Evaluation of Microneedle Arrays for Ocular Drug DeliverySchool of Pharmacy | PHD Drug delivery, sustained release, controlled release, nanomaterials, microparticles, hydrogels, ocul Prof Raghu Raj Singh Thakur..
Supervisor
Prof Raghu Raj Singh Thakur..
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Polymer-engineering nanocages for protein deliverySchool of Pharmacy | PHD Protein delivery, biotherapeutics, stimuli-responsive polymers, bioconjugation, nanocages, polymer Dr Sheiliza Carmali
Supervisor
Dr Sheiliza Carmali
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Enhancing Protein Thermal Stability for Melt ProcessingSchool of Pharmacy | PHD Proteins, biotherapeutics, hot-melt extrusion, continuous manufacturing, bioconjugation Dr Sheiliza Carmali
Supervisor
Dr Sheiliza Carmali
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Synthetic Protein-Transporters for Enhanced Transduction ActivitySchool of Pharmacy | PHD Intracellular protein delivery, biotherapeutics, bioconjugation, thiol-mediated uptake Dr Sheiliza Carmali
Supervisor
Dr Sheiliza Carmali
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Catalytic nanocages for in situ drug deliverySchool of Pharmacy | PHD Biocatalysis; prodrugs; therapeutic nanoreactors; in situ chemotherapeutics Dr Sheiliza Carmali.
Supervisor
Dr Sheiliza Carmali.
Funding
Funded
Department of Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Investigating the impact of the gut microbiome on the health of older peopleSchool of Pharmacy | PHD Microbiome; bioinformatics; clinical; ageing; medicines; older people Dr Stephen Kelly
Supervisor
Dr Stephen Kelly
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Mechanochemical synthesis of polymer-drug conjugates via reactive extrusionSchool of Pharmacy | PHD Polymer-drug conjugates, solvent-less mechanochemical conjugation, mechanochemistry Dr Shu Li
Supervisor
Dr Shu Li
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of Multi-Drug Sutures using Deep Eutectic Reactive Technology for the Prevention of Surgical Site InfectionsSchool of Pharmacy | PHD Surgical site infection, surgical sutures, drug-eluting sutures, antimicrobial, reactive extrusion, Dr Shu Li.
Supervisor
Dr Shu Li.
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of Multi-Drug Sutures using Deep Eutectic Reactive Technology for the Prevention of Surgical Site InfectionsSchool of Pharmacy | PHD Dr Shu Li
Supervisor
Dr Shu Li
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Bio-inspired liquid-like coatings for medical devices to combat biofilms and associated infectionsSchool of Pharmacy | PHD Biomaterials; Infection; Surface; Medical devices Dr Shuai Zhang
Supervisor
Dr Shuai Zhang
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Highly durable non-releasing antimicrobial coatings for catheters to combat catheter-associated urinary tract infectionsSchool of Pharmacy | PHD infection; surface; coating; biofilm; polymer; hydrogel Dr Shuai Zhang
Supervisor
Dr Shuai Zhang
Funding
Funded
Department of Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of dual-functional antibacterial and antifungal polymers to prevent medical device-associated infectionsSchool of Pharmacy | PHD infection; surface; coating; biofilm; polymer; hydrogel Dr Shuai Zhang
Supervisor
Dr Shuai Zhang
Funding
Funded
Department of Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Novel multifunctional hydrogel wound dressings for diabetic foot ulcer healingSchool of Pharmacy | PHD infection; surface; coating; biofilm; polymer; hydrogel Dr Shuai Zhang
Supervisor
Dr Shuai Zhang
Funding
Funded
Department for Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of multifunctional biomaterials for urinary catheters to eradicate catheter-associated urinary tract infectionsSchool of Pharmacy | PHD Biomaterials; Medical devices; Infections; Inflammation; Biofilm Dr Shuai Zhang.
Supervisor
Dr Shuai Zhang.
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Safer, scalable, and modifiable polymer-based lipid nanocapsules for drug deliverySchool of Pharmacy | PHD Lipid nanocapsules, drug delivery, nanotechnology, green chemistry, polymer science. Dr Taher Hatahet
Supervisor
Dr Taher Hatahet
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Development of antioxidants-based nanoparticles for topical applicationSchool of Pharmacy | PHD Vaginal gels; drug delivery; bacterial vaginosis; formulation; Dr Taher Hatahet
Supervisor
Dr Taher Hatahet
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of next-generation nanoparticles loaded hydrogels containing multiple active agents for improved treatment of bacterial infectionsSchool of Pharmacy | PHD hydrogels; drug delivery; bacterial infections; formulation; antimicrobial resistance Dr Taher Hatahet
Supervisor
Dr Taher Hatahet
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Development of anti-inflammatory-based nanoparticles for topical treatment of psoriasisSchool of Pharmacy | PHD Vaginal gels; drug delivery; bacterial vaginosis; formulation; Dr Taher Hatahet
Supervisor
Dr Taher Hatahet
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Combinations of bacteriophages and cold plasma for biofilm biocontrolSchool of Pharmacy | PHD Bacteriophage, phage, endolysin, cold plasma Dr Timofey Skvortsov
Supervisor
Dr Timofey Skvortsov
Funding
Funded
DfE Funded, Self-Funded, CSC
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Improved delivery of bacteriophages and phage-derived antibacterial agentsSchool of Pharmacy | PHD Bacteriophage, endolysins, skin, biofilms, deep eutectic solvents, formulation Dr Timofey Skvortsov
Supervisor
Dr Timofey Skvortsov
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Freeze-dried bacteriophage formulations against antibiotic-resistant bacteriaSchool of Pharmacy | PHD Dr. Timofey Skvortsov
Supervisor
Dr. Timofey Skvortsov
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Nanoparticle delivery of antibiotics for treatment of pulmonary infectionSchool of Pharmacy | PHD inhaled, nanoparticles, drug delivery, mucosal, pharmaceutical, bacteria Dr Vicky Kett
Supervisor
Dr Vicky Kett
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Vaccine-drying stabilisation strategiesSchool of Pharmacy | PHD Pharmaceutics, vaccine, pharmaceutical formulation, drug delivery, liposomes Dr Vicky Kett
Supervisor
Dr Vicky Kett
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Liposomal Antibiotic for Improved Treatment of Respiratory InfectionSchool of Pharmacy | PHD Dr Vicky Kett
Supervisor
Dr Vicky Kett
Funding
Funded
Department of Economy (DfE)
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Self-Navigating Nanocarriers for Intracellular Protein DeliverySchool of Pharmacy | PHD Biologics, protein delivery, nanomedicine, intracellular delivery Professor Wafa Al-Jamal
Supervisor
Professor Wafa Al-Jamal
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
Investigating new excipients to improve ionizable lipid nanoparticles’ endosomal escape and enhance gene expressionSchool of Pharmacy | PHD Gene delivery, ionisable lipid nanoparticles (LNPs), microfluidics, nucleic acids Professor Wafa Al-Jamal
Supervisor
Professor Wafa Al-Jamal
Funding
Funded
Department for Economy
Application deadline
31 January 2025
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | 1738281600 |
Non-thermal irreversible electroporation to treat advanced cancerSchool of Pharmacy | PHD Professor Wafa Al-Jamal.
Supervisor
Professor Wafa Al-Jamal.
Funding
Funded
Department for Economy
Application deadline
None specified
|
School of Pharmacy | Funded | Pharmacy | Open | 2 | |
Antibiotic use and lower respiratory tract infections burden in children during Coronavirus (COVID-19)School of Pharmacy | PHD Pharmaco-epidemiology, children, machine learning, infection disease, COVID-19 Dr Yingfen Hsia
Supervisor
Dr Yingfen Hsia
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Closed | 2 | |
In-cell quantification of drug concentrations by using advanced nano-sensorSchool of Pharmacy | PHD Nanomedicine, Nanotechnology, Nanomaterials, Sensing, Senor, Biosensor, Bioengineering Dr Yi Ge
Supervisor
Dr Yi Ge
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 | |
Developing cost-effective and eco-friendly antiviral nano-agentsSchool of Pharmacy | PHD Nanomedicine, Nanotechnology, Nanomaterials, Biomaterials, COVID-19, Antiviral agents, Virus Dr Yi Ge
Supervisor
Dr Yi Ge
Funding
Unfunded
Application deadline
None specified
|
School of Pharmacy | Unfunded | Pharmacy | Open | 2 |
Entrance requirements
Graduate
The minimum academic requirement for admission to a research degree programme is normally an Upper Second Class Honours degree from a UK or ROI HE provider, or an equivalent qualification acceptable to the University.
International Students
For information on international qualification equivalents, please check the specific information for your country.
English Language Requirements
Evidence of an IELTS* score of 6.0, with not less than 6.0 in writing, and not less than 5.5 in listening, speaking and reading, or an equivalent qualification acceptable to the University is required. *Taken within the last 2 years.
International students wishing to apply to Queen's University Belfast (and for whom English is not their first language), must be able to demonstrate their proficiency in English in order to benefit fully from their course of study or research. Non-EEA nationals must also satisfy UK Visas and Immigration (UKVI) immigration requirements for English language for visa purposes.
For more information on English Language requirements for EEA and non-EEA nationals see: www.qub.ac.uk/EnglishLanguageReqs.
If you need to improve your English language skills before you enter this degree programme, INTO Queen's University Belfast offers a range of English language courses. These intensive and flexible courses are designed to improve your English ability for admission to this degree.
Tuition Fees
Northern Ireland (NI) 1 | TBC |
Republic of Ireland (ROI) 2 | TBC |
England, Scotland or Wales (GB) 1 | TBC |
EU Other 3 | £25,600 |
International | £25,600 |
1 EU citizens in the EU Settlement Scheme, with settled or pre-settled status, are expected to be charged the NI or GB tuition fee based on where they are ordinarily resident, however this is provisional and subject to the publication of the Northern Ireland Assembly Student Fees Regulations. Students who are ROI nationals resident in GB are expected to be charged the GB fee, however this is provisional and subject to the publication of the Northern Ireland Assembly student fees Regulations.
2 It is expected that EU students who are ROI nationals resident in ROI will be eligible for NI tuition fees. The tuition fee set out above is provisional and subject to the publication of the Northern Ireland Assembly student fees Regulations.
3 EU Other students (excludes Republic of Ireland nationals living in GB, NI or ROI) are charged tuition fees in line with international fees.
All tuition fees quoted relate to a single year of study unless stated otherwise. All fees will be subject to an annual inflationary increase, unless explicitly stated otherwise.
More information on postgraduate tuition fees.
Pharmacy costs
Additional course costs
All Students
Depending on the programme of study, there may also be other extra costs which are not covered by tuition fees, which students will need to consider when planning their studies . Students can borrow books and access online learning resources from any Queen's library. If students wish to purchase recommended texts, rather than borrow them from the University Library, prices per text can range from £30 to £100. Students should also budget between £30 to £100 per year for photocopying, memory sticks and printing charges. Students may wish to consider purchasing an electronic device; costs will vary depending on the specification of the model chosen. There are also additional charges for graduation ceremonies, and library fines. In undertaking a research project students may incur costs associated with transport and/or materials, and there will also be additional costs for printing and binding the thesis. There may also be individually tailored research project expenses and students should consult directly with the School for further information.
Bench fees
Some research programmes incur an additional annual charge on top of the tuition fees, often referred to as a bench fee. Bench fees are charged when a programme (or a specific project) incurs extra costs such as those involved with specialist laboratory or field work. If you are required to pay bench fees they will be detailed on your offer letter. If you have any questions about Bench Fees these should be raised with your School at the application stage. Please note that, if you are being funded you will need to ensure your sponsor is aware of and has agreed to fund these additional costs before accepting your place.
How do I fund my study?
1.PhD OpportunitiesFind PhD opportunities and funded studentships by subject area.
2.Funded Doctoral Training ProgrammesWe offer numerous opportunities for funded doctoral study in a world-class research environment. Our centres and partnerships, aim to seek out and nurture outstanding postgraduate research students, and provide targeted training and skills development.
3.PhD loansThe Government offers doctoral loans of up to £26,445 for PhDs and equivalent postgraduate research programmes for English- or Welsh-resident UK and EU students.
4.International ScholarshipsInformation on Postgraduate Research scholarships for international students.
Funding and Scholarships
The Funding & Scholarship Finder helps prospective and current students find funding to help cover costs towards a whole range of study related expenses.
How to Apply
Apply using our online Postgraduate Applications Portal and follow the step-by-step instructions on how to apply.
Find a supervisor
If you're interested in a particular project, we suggest you contact the relevant academic before you apply, to introduce yourself and ask questions.
To find a potential supervisor aligned with your area of interest, or if you are unsure of who to contact, look through the staff profiles linked here.
You might be asked to provide a short outline of your proposal to help us identify potential supervisors.